Docket

39530

Amgen Inc., et al. v. Pfizer Canada ULC

(Federal Court) (Civil) (By Leave)

(Certain information not available to the public)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2021-07-08 Close file on Leave
2021-07-08 Judgment on leave sent to the parties
2021-07-08 Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-122-20, 2020 FCA 188, dated November 3, 2020, is dismissed with costs.
Dismissed, with costs
2021-06-07 All materials on application for leave submitted to the Judges, for consideration by the Court
2021-03-01 Certificate (on limitations to public access), (Letter Form), 23B-Reply, (Printed version due on 2021-03-08) Amgen Inc.
2021-03-01 Applicant's reply to respondent's argument, (Letter Form), Completed on: 2021-05-14, (Printed version due on 2021-03-08) Amgen Inc.
2021-02-19 Certificate (on limitations to public access), (Letter Form), (Included in the certificate (on limitations to public access)), 23B, (Printed version due on 2021-02-26) Pfizer Canada ULC
2021-02-19 Certificate (on limitations to public access), (Letter Form), 23A

received: confidentiality order (received 2021-02-19), (Printed version filed on 2021-02-19)
Pfizer Canada ULC
2021-02-19 Notice of name, (Letter Form), (Printed version due on 2021-02-26) Pfizer Canada ULC
2021-02-19 Respondent's response on the application for leave to appeal, (Book Form), CONFIDENTIAL

Confidential paper material filed 2021-02-19
Confidential electronic material filed 2021-03-17
Redacted electronic material filed 2021-02-19, Completed on: 2021-05-14, (Printed version filed on 2021-02-19)
Pfizer Canada ULC
2021-01-22 Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED: 2021-01-22
2021-01-04 Certificate (on limitations to public access), Form 23B
Amended version (Rec'd 2021-01-08), (Printed version filed on 2021-01-05)
Amgen Inc.
2021-01-04 Certificate (on limitations to public access), (Letter Form), Form 23A
Required clarification RE 23A (Rec'd amended 23 A 2021-01-08.), (Printed version filed on 2021-01-05)
Amgen Inc.
2021-01-04 Notice of name Amgen Inc.
2021-01-04 Application for leave to appeal, (Book Form), CONFIDENTIAL: FC reasons for judgment are Confidential and were filed separately.
Public reasons for judgment filed with the application.

Required clarification RE 23A (Rec'd amended 23A and 23B 2021-01-08.), Completed on: 2021-01-04
Amgen Inc.